<DOC>
	<DOCNO>NCT00168389</DOCNO>
	<brief_summary>This study evaluate safety efficacy intravitreal implant dexamethasone treatment diabetic macular edema .</brief_summary>
	<brief_title>A Study Safety Efficacy New Treatment Diabetic Macular Edema</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Key 18 year age old diabetic macular edema ; Decrease visual acuity least one eye result macular edema ( 20/50 worse ) ; Visual acuity eye worse 20/200 Key Known anticipate need ocular surgery within first 12 month study ; History glaucoma current high eye pressure require 1 medication ; Uncontrolled systemic disease ; Known steroidresponder ; Use systemic steroid Use Warfarin/Heparin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>